Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8104976rdf:typepubmed:Citationlld:pubmed
pubmed-article:8104976lifeskim:mentionsumls-concept:C0033809lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0002556lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0449943lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0242646lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0020008lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0205453lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C2827424lld:lifeskim
pubmed-article:8104976lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:8104976pubmed:issue2lld:pubmed
pubmed-article:8104976pubmed:dateCreated1993-10-26lld:pubmed
pubmed-article:8104976pubmed:abstractTextA total of 1896 isolates of Pseudomonas aeruginosa resistant to aminoglycosides and isolated during the period 1983-1989 in two Belgian general hospitals were included in this study. The most frequently encountered O serotypes were O4, O11, O12 and non-typable isolates. The majority of the isolates showed resistance to extended spectrum beta-lactam antibiotics (cefotaxime, ceftriaxone and cefepime). However, a low degree of resistance was found for ceftazidime. By contrast, amikacin and isepamicin, remained active on a significant number of aminoglycoside resistant isolates. In both hospitals, impermeability and AAC(3)II enzyme production were the most prevalent aminoglycoside resistance mechanisms. There were marked differences between the two hospitals with regard to the distribution of the O-serotypes and resistance profiles.lld:pubmed
pubmed-article:8104976pubmed:languageenglld:pubmed
pubmed-article:8104976pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:citationSubsetIMlld:pubmed
pubmed-article:8104976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8104976pubmed:statusMEDLINElld:pubmed
pubmed-article:8104976pubmed:monthJunlld:pubmed
pubmed-article:8104976pubmed:issn0195-6701lld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:GodardCClld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:Hannecart-Pok...lld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:VanhoofRRlld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:HubrechtsJ...lld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:MaesPPlld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:NyssenH JHJlld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:NulensEElld:pubmed
pubmed-article:8104976pubmed:authorpubmed-author:WildemauweCClld:pubmed
pubmed-article:8104976pubmed:issnTypePrintlld:pubmed
pubmed-article:8104976pubmed:volume24lld:pubmed
pubmed-article:8104976pubmed:ownerNLMlld:pubmed
pubmed-article:8104976pubmed:authorsCompleteYlld:pubmed
pubmed-article:8104976pubmed:pagination129-38lld:pubmed
pubmed-article:8104976pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:meshHeadingpubmed-meshheading:8104976-...lld:pubmed
pubmed-article:8104976pubmed:year1993lld:pubmed
pubmed-article:8104976pubmed:articleTitleSerotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.lld:pubmed
pubmed-article:8104976pubmed:affiliationUnit of Antibiotic Research, Institute Pasteur of Brabant, Brussels, Belgium.lld:pubmed
pubmed-article:8104976pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8104976pubmed:publicationTypeComparative Studylld:pubmed